K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
Kwang Hyub Han,Do Young Kim,Jun Yong Park,Sang Hoon Ahn,Jieun Kim,Seung Up Kim,Ja Kyung Kim,Kwan Sik Lee,Chae Yoon Chon +8 more
TL;DR: Using a Cox regression model, Child-Pugh class, Japanese tumor-node-metastasis stage, and &agr;-fetoprotein levels were independently associated with patient survival.
Journal ArticleDOI
Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis.
Do Young Kim,Jie Hyun Kim,Chae Yoon Chon,Kwang Hyub Han,Sang Hoon Ahn,Ja Kyung Kim,Yong Han Paik,Kwan Sik Lee,Young Myoung Moon +8 more
TL;DR: This study assesses the usefulness of two different reagent strips, the UriSCAN and the Multistix10SG, for the rapid bedside diagnosis of SBP.
Journal ArticleDOI
Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
Sang Won Lee,Hee Jin Park,Beom Kyung Kim,Kwang Hyub Han,Soo Kon Lee,Seung Up Kim,Yong Beom Park +6 more
TL;DR: The cumulative dose of leflunomide was the only independent predictor of abnormal LSM values in patients with RA who had received methotrexate for more than six months.
Journal ArticleDOI
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
Yanni Yan Ni Lui,Kelvin K.F. Tsoi,Vincent Wai-Sun Wong,Jia-Horng Kao,Jin Lin Hou,Eng Kiong Teo,Rosmawati Mohamed,Teerha Piratvisuth,Kwang Hyub Han,Ulrike Mihm,Grace Lai-Hung Wong,Henry Lik-Yuen Chan +11 more
TL;DR: In HBeAg-positive patients, lamivudine roadmap was most cost-effective; in Asia, telbivudines roadmap had comparable cost-effectiveness to lamivUDine roadmap because of the relatively low price of telb Vivudine in Asia.
Journal ArticleDOI
Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
Alexander König,Jaewon Yang,Eunji Jo,Kyu Ho Paul Park,Hyun Kim,Thoa Thi Than,Xiyong Song,Xiaoxuan Qi,Xinghong Dai,Soonju Park,David Shum,Wang-Shick Ryu,Jung-Hee Kim,Seung Kew Yoon,Jun Yong Park,Sang Hoon Ahn,Kwang Hyub Han,Wolfram H. Gerlich,Marc P. Windisch +18 more
TL;DR: The novel HepG2-NTCPsec+ cells efficiently support the complete HBV life cycle, long-term viral spread and amplification of HBV derived from patients or cell culture, resembling relevant features ofHBV-infected patients.